Immunohistochemical expression of c-KIT protein in feline soft tissue fibrosarcomas

Veterinary Pathology

Volumn 46, Issue 5, 2009, Pages 934-939

  Smith, A J ^a   Njaa, B L ^a   Lamm, C G ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

c KIT; Cats; CD117; Fibrosarcoma; Immunohistochemistry; p145; Proto oncogene protein KIT

Indexed keywords

STEM CELL FACTOR RECEPTOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; FEMALE; FIBROSARCOMA; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PATHOLOGY; RETROSPECTIVE STUDY; SOFT TISSUE TUMOR; SURVIVAL;

ANIMALS; CAT DISEASES; CATS; FEMALE; FIBROSARCOMA; IMMUNOHISTOCHEMISTRY; MALE; PROTO-ONCOGENE PROTEINS C-KIT; RETROSPECTIVE STUDIES; SOFT TISSUE NEOPLASMS; SURVIVAL ANALYSIS;

ANIMALIA; FELIDAE; FELIS CATUS;

EID: 77149166372     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1354/vp.08-VP-0219-L-FL     Document Type: Article

References (36)

1. Aberdein D, Dyer CB, Knight CG, French AF, Gibson IR: Comparison of the histology and immunohistochemistry of vaccination-site and non-vaccination-site sarcomas from cats in New Zealand. N Z VetJ 55:203-207, 2007
2. Besmer P, Murphy JE, George PC, Qiu FH, Bergold PJ, Lederman L, Snyder HW Jr., Brodeur D, Zuckerman EE, Hardy WD: A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 320:415-421, 1986
3. Bostock DE: Neoplasms of the skin and subcutaneous tissues in dogs and cats. Br Vet J 142:1-19, 1986
4. Bostock DE, Dye MT: Prognosis after surgical excision of canine fibrous connective tissue sarcomas. Vet Pathol 17:581-588, 1980
5. Bostock DE, Dye MT: Prognosis after surgical excision of fibrosarcomas in cats. J Am Vet Med Assoc 175:727-728, 1979
6. Cuoto SS, Griffey SM, Duarte PC, Madewell BR: Feline vaccine-associated fibrosarcoma: morphological distinctions. Vet Pathol 29:33-41, 2002
7. Dernell WS, Kuntz CA, Powers BE: Principles of treatment for soft tissue sarcoma. Clin Tech Small Anim Pract 13:59-64, 1998
8. Dobson JM, Scase TJ: Advances in the diagnosis and management of cutaneous mast cell tumours in dogs. J Small Anim Pract 48:424-431, 2007
9. Doddy FD, Glickman LT, Glickman NW, Janovitz EB: Feline fibrosarcomas at vaccination sites and non-vaccination sites. J Comp Pathol 114:165-174, 1996
10. Gibson PC, Cooper K: CD117 (KIT): a diverse protein with selective applications in surgical pathology. Adv Anat Pathol 9:65-69, 2002
11. Gleixner KV, Rebuzzi L, Mayerhofer M, Gruze A, Hadzijusufovic E, Sonneck K, Vales A, Kneidinger M, Samorapoompichit P, Thaiwong T, Pickl WF, Yuzbasiyan-Gurkan V, Sillaber C, Willmann M, Valent P: Synergistic antiproliferative effects of KIT tyrosine kinase inhibitors on neoplastic canine mast cells. Exp Hematol 35:1510-1521, 2007
12. Hendrick MJ, Shofer FS, Goldschmidt MH, Haviland JC, Schelling SH, Engler SJ, Gliatto JM: Comparison of fibrosarcomas that developed at vaccination sites and at nonvaccination sites in cats: 239 cases (1991-1992). J Am Vet Med Assoc 205:1425-1429, 1994
13. Herbst R, Munemitsu S, Ullrich A: Oncogenic activation of v-kit involves deletion of a putative tyrosine-substrate interaction site. Oncogene 10: 369-379, 1995
14. Hershey AE, Sorenmo KU, Hendrick MJ, Shofer FS, Vail DM: Prognosis for presumed feline vaccineassociated sarcoma after excision: 61 cases (1986-1996). J Am Vet Med Assoc 216:58-61, 2000
15. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577-580, 1998
16. Hirota S, Nishida T, Isozaki K, Taniguchi M, Nishikawa K, Ohashi A, Takabayashi A, Obayashi T, Okuno T, Kinoshita K, Chen H, Shinomura Y, Kitamura Y: Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT gene. Gastroenterology 122:1493-1499, 2002
17. Isotani M, Tamura K, Yagihara H, Hikosaka M, Ono K, Washizu T, Bonkobara M: Identification of a c-kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate. Vet Immunol Immunopathol 114:168-172, 2006
18. Joensuu H: Treatment of inoperable gastrointestinal stromal tumor (GIST) with imatinib (Glivec, Gleevec). Med Klin (Munich) 97(Suppl 1):28-30, 2002
19. Kass PH, Barnes WG Jr, Spangler WL, Chomel BB, Culbertson MR: Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. J Am Vet Med Assoc 203: 396-405, 1993
20. Kitamura Y, Hirota S, Nishida T: Gastrointestinal stromal tumors (GIST): a model for molecule-based diagnosis and treatment of solid tumors. Cancer Sci 94:315-320, 2003
21. Kobie K, Kawabata M, Hioki K, Tanaka A, Matsuda H, Mori T, Maruo K: The tyrosine kinase inhibitor imatinib [STI571] induces regression of xenografted canine mast cell tumors in SCID mice. Res Vet Sci 82:239-241, 2007
22. Kuntz CA, Dernell WS, Powers BE, Devitt C, Straw RC, Withrow SJ: Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996). J Am Vet Med Assoc 211:1147-1151, 1997
23. London CA, Galli SJ, Yuuki T, Hu ZQ, Helfand SC, Geissler EN: Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit. Exp Hematol 27:689-697, 1999
24. London CA, Hannah AL, Zadovoskaya R, Chien MB, Kollias-Baker C, Rosenberg M, Downing S, Post G, Boucher J, Shenoy N, Mendel DB, McMahon G, Cherrington JM: Phase I doseescalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. Clin Cancer Res 9:2755-2768, 2003
25. London CA, Kisseberth WC, Galli SJ, Geissler EN, Helfand SC: Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumours. J Comp Pathol 115:399-414,1996
26. Majumder S, Ray P, Besmer P: Tyrosine protein kinase activity of the HZ4-feline sarcoma virus P80gag-kit-transforming protein. Oncogene Res 5: 329-335, 1990
27. Morini M, Bettini G, Preziosi R, Mandrioli L: C-kit gene product (CD117) immunoreactivity in canine and feline paraffin sections. J Histochem Cytochem 52:705-708, 2004
28. Nakahara M, Isozaki K, Hirota S, Miyagawa J, Hase-Sawada N, Taniguchi M, Nishida T, Kanayama S, Kitamura Y, Shinomura Y, Matsuzawa Y: A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors. Gastroenterology 115:1090-1095, 1998
29. Nocka K, Buck J, Levi E, Besmer P: Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. EMBO J 9:3287-3294, 1990
30. Powers BE, Hoopes PJ, Ehrhart EJ: Tumor diagnosis, grading, and staging. Semin Vet Med Surg (Small Anim) 10:158-167, 1995
31. Romanelli G, Marconato L, Olivero D, Massari F, Zini E: Analysis of prognostic factors associated with injection-site sarcomas in cats: 57 cases (2001-2007). J Am Vet Med Assoc 232:1193-1199, 2008
32. Rutkowski P, Symonides M, Zdzienicki M, Siedlecki JA: Developments in targeted therapy of advanced gastrointestinal stromal tumors. Recent Pat Anti-cancer Drug Discov 3:88-99, 2008
33. Webster JD, Kiupel M, Kaneene JB, Miller R, Yuzbasiyan-Gurkan V: The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Vet Pathol 41:371-377, 2004
34. Webster JD, Yuzbasiyan-Gurkan V, Kaneene JB, Miller R, Resau JH, Kiupel M: The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors. Neoplasia 8:104-111, 2006
35. Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A: Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341-3351, 1987
36. Zemke D, Yamini B, Yuzbasiyan-Gurkan V: Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs. Vet Pathol 39:529-535, 2002